Boehringer Ingelheim (BI) wanted to use a chatbot to engage with users and draw out more insight than a standard web questionnaire. The aim was to make users aware of their asthma symptoms and to discuss them with their doctor.
We developed Tabatha, a robust chatbot with Natural Language Processing (NLP) capabilities to help asthma sufferers understand and manage their condition.
Tabatha was deployed to Facebook Messenger and was launched on the ‘Asthma: Think, Act, Breathe’ Facebook page in time for World Asthma Day in 2017.
Tabatha was the first chatbot for global patient education ever developed by a pharmaceutical company and she engaged with 3,800 users over the first 2 weeks of being live, far exceeding the engagement levels of the previous web questionnaire.